{
    "code": "60001174",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001174",
    "time": "2023-09-07 19:59:14",
    "許可證字號": "衛部菌疫輸字第001174號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/09\/07",
    "發證\/登錄日期": "110\/09\/07",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000117404",
    "中文品名": "倍優視注射劑120毫克\/毫升",
    "英文品名": "Beovu 120 mg\/mL solution for injection",
    "適應症": "1.治療血管新生型(濕性)年齡相關性黃斑部退化病變(Neovascular (Wet)) Age-Related Macular Degeneration, wAMD)。\r\n2.糖尿病黃斑部水腫(Diabetic macular oedema, DME)所導致的視力損害。",
    "劑型": "27D注射液劑",
    "包裝": "0.23mL玻璃瓶裝附過濾針頭，100瓶以下盒裝 0.165mL預充填注射針筒裝，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "115\/09\/07",
    "主成分略述": "Brolucizumab",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5F免除銜接性試驗",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "臺北市中山區民生東路3段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "S.A. ALCON-COUVREUR N.V.",
            "製造廠廠址": "RIJKSWEG 14, 2870 PUURS, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "溶劑及注射針筒廠"
        },
        {
            "製造廠名稱": "NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "CH-4002,BASEL,SWITZERLAND",
            "製造廠國別": "SWITZERLAND",
            "製程": "成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "Sandoz GmbH",
            "製造廠廠址": "BIOCHEMIESTRASSE 10, 6250 KUNDL AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010400100",
            "成分名稱": "Brolucizumab",
            "含量描述": "",
            "含量": "120.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Beovu-TWI-201221-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=001&Type=9"
        },
        {
            "title": "Beovu PFS LBL (765241_U12, prt)-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=007&Type=8"
        },
        {
            "title": "Beovu PFS Foil (554561_U12, prt)-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=006&Type=8"
        },
        {
            "title": "Beovu PFS FB (788541_U12, prt)-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=005&Type=8"
        },
        {
            "title": "Beovu LIVI LBL-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=004&Type=8"
        },
        {
            "title": "Beovu LIVI FB-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=003&Type=8"
        },
        {
            "title": "Beovu (vial) label_cht_TWL-031121-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=002&Type=8"
        },
        {
            "title": "Beovu (PFS) label_cht_TWL-021121-111-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001174&Seq=001&Type=8"
        }
    ]
}